Oncology and Hematology
241-256 of 743
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
- Oncology and Hematology
Additional Safey Data From TROPION-Breast02 and Study Design of TROPION-Breast06
Komal Jhaveri, MD, FACP
- MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program creditA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
Casey Cosgrove, MD
Alexandria May, PharmD, BCPS
Daniel Landi, MD
Brian Slomovitz, MD
Brian Slomovitz, MD
Victoria Coleman-Cowger, PhD
Ryan Quigley
- Project Oncology®
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Ryan Quigley
